CIK 0001159036 · Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880488686
- Phone
- (858) 794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,884,955
- in 5 filings, $19.9M under 10b5-1 plans
Net −$19,884,955. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-02 | Lang James Paul Director | Grant or award | +889 | 889 | ||
| 2026-01-02 | Lang James Paul Director | Grant or award · Option to Purchase Common Stock | +1,342 | 1,342 | ||
| 2025-12-09 | Torley Helen PRESIDENT AND CEO | Grant or award · Performance Stock Units | +165,522 | 165,522 | ||
| 2025-12-01 | Connaughton Bernadette Director | Sale 10b5-1 | −829 | $71.60 | $59K | 42,123 |
| 2025-12-01 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +16,569 | $8.11 | $134K | 725,288 |
| 2025-12-01 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −10,406 | $68.51 | $713K | 714,882 |
| 2025-12-01 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −5,402 | $69.44 | $375K | 709,480 |
| 2025-12-01 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −500 | $70.36 | $35K | 708,980 |
| 2025-12-01 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −261 | $71.60 | $19K | 708,719 |
| 2025-12-01 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −16,569 | $8.11 | $134K | 0 |
| 2025-11-26 | Torley Helen PRESIDENT AND CEO | Gift 10b5-1 | −25,000 | 708,719 | ||
| 2025-11-12 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +20,000 | $8.11 | $162K | 753,719 |
| 2025-11-12 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −12,718 | $70.22 | $893K | 741,001 |
| 2025-11-12 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −6,784 | $71.09 | $482K | 734,217 |
| 2025-11-12 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −498 | $71.67 | $36K | 733,719 |
| 2025-11-12 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $8.11 | $162K | 16,569 |
| 2025-11-11 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +20,000 | $8.11 | $162K | 753,719 |
| 2025-11-11 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −4,500 | $67.89 | $306K | 749,219 |
| 2025-11-11 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −4,000 | $68.80 | $275K | 745,219 |
| 2025-11-11 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −11,500 | $69.73 | $802K | 733,719 |
Page 13 of 26 · 513 trades